Skip to main content

Table 1 The aberrant expressions of BKCa, ERK1/2 and p-ERK1/2 in tissue samples of type I endometrial carcinoma, atypical endometrial hyperplasia and normal endometrium

From: BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway

Proteins Expression level Endometrial adenocarcinoma (n = 185) Atypical endometrial hyperplasia (n = 38) Normal endometrium (n = 40)
BKCa High 68 2 2
Low 117 36 38
ERK1/2 High 110 5 2
Low 75 33 38
p-ERK1/2 High 93 12 1
Low 92 26 39